{"query":"alamarbio.com","mode":"domain","best":{"domain":"alamarbio.com","status":"valid","tier":"listed","authority":48,"verified":false,"title":"Alamar Biosciences - Precision Proteomics for Biomarker Discovery","summary":"About: Alamar Biosciences is a leader in precision proteomics dedicated to advancing early disease detection through the NULISA™ platform and ARGO™ HT System. The company develops high-sensitivity, high-throughput protein analysis solutions designed for biomarker discovery, validation, and translational research across therapeutic areas including neurology, immunology, and oncology.","country":"US","country_source":"ip","publisher_country":null,"publisher_country_source":null,"hosting_country":"US","llms_txt":"https://alamarbio.com/llms.txt","llms_full_txt":null,"last_checked":"2026-10-23T22:02:24.698Z","agent_terms":null,"categories":["science-research"],"capabilities":[],"inferred_tags":["proteomics","biomarker discovery","nulisa","argo ht system","early disease detection","translational research"],"audience":"business","agent_uses":["read_docs"],"language":"en","platform_generated":false,"agent_summary":"Alamar Biosciences, a precision proteomics company offering the NULISA platform and ARGO HT System for high-throughput biomarker discovery and translational res","llms_txt_cached":"https://agentwebmap.com/v1/domain/alamarbio.com/llms.txt","agentic":"documentation","section_keys":["additional-resources","attomolar-sensitivity-immunoassay-alternatives","best-alternative-to-traditional-elisa-for-high-throughput-biomarker-discovery","blood-tests-that-measure-ptau217-and-amyloid-beta-42-together","high-plex-proteomics-for-immune-oncology","high-throughput-proteomics-platforms-for-biomarker-discovery","how-to-detect-low-abundance-cytokines-in-plasma","multiplex-blood-assay-for-multiple-tau-isoforms-and-neuroinflammation","multiplexed-blood-biomarker-panels-for-parkinson-s-disease","platform-for-detecting-pg-ml-and-sub-pg-ml-protein-levels-in-multiplex-format","top-5-proteomics-platforms-used-by-big-pharma-for-large-cohort-blood-biomarker-discovery","what-makes-p-tau217-superior-to-p-tau181-and-p-tau231-as-an-alzheimer-s-blood-biomarker"],"section_partial":false,"section_indexed_at":"2026-10-21T14:25:10.272Z","why":["authority 48 (listed)","checked 1245 minutes ago"]},"read":{"llms_txt":"https://alamarbio.com/llms.txt","llms_full_txt":null,"nested_llms_txt":[]},"terms":null,"health":{"ok":true,"status":"valid","tier":"listed","authority":48,"last_checked":"2026-10-23T22:02:24.698Z","checked_minutes_ago":1244,"stale":false,"max_age_seconds":86400,"live_checked":false,"http_status":200,"last_valid":"2026-10-23T22:02:24.698Z","content_hash":"4098d6549d5f383e3e797b94f61ae139","documentation_indexed_at":"2026-10-21T04:45:41.847Z"},"sources":[],"match":{"strength":"domain","reason":"Exact domain or its registered publisher."},"provenance":{"selection":"directory","reranked":false,"verification":"domain_ownership","terms":"unknown","excerpts":"publisher_link_metadata","health":"stored_crawl"},"alternatives":[]}